Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor A Umans

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Nephrology|March 19, 2021
Personalized screening intervals for kidney function in patients with chronic heart failure: a modeling studyAnne-Sophie Schuurman, Anirudh Tomer, K Martijn Akkerhuis, et al.
Heart (British Cardiac Society)|August 29, 2014
Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEFNick van Boven, Stephan Windecker, Victor A Umans, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 15, 2017
Development and validation of a risk model for long-term mortality after percutaneous coronary intervention: The IDEA-BIO StudyNick van Boven, Ron T van Domburg, Isabella Kardys, et al.
The American Journal of Cardiology|January 20, 2022
Relation of Iron Status to Prognosis After Acute Coronary SyndromeMuhammed T Gürgöze, Isabella Kardys, K Martijn Akkerhuis, et al.
Diabetes & Vascular Disease Research|December 1, 2021
IGF-1 is not related to long-term outcome in hyperglycemic acute coronary syndrome patientsCindya P Iswandi, Victor J van den Berg, Suat Simsek, et al.
Biology of Sex Differences|May 17, 2023
Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failureMarie de Bakker, Teun B Petersen, K Martijn Akkerhuis, et al.
International Journal of Cardiology|March 10, 2017
Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT studyNick van Boven, K Martijn Akkerhuis, Sharda S Anroedh, et al.
Obesity (Silver Spring, Md.)|July 23, 2024
Proteomic biomarkers related to obesity in heart failure with reduced ejection fraction and their associations with outcomeTeun B Petersen, Navin Suthahar, Folkert W Asselbergs, et al.
Ebiomedicine|June 16, 2023
HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanismsTeun B Petersen, Marie de Bakker, Folkert W Asselbergs, et al.
European Heart Journal. Digital Health|December 4, 2023
Machine learning-based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failureMarie de Bakker, Teun B Petersen, Anja J Rueten-Budde, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Nephrology|March 19, 2021
Personalized screening intervals for kidney function in patients with chronic heart failure: a modeling studyAnne-Sophie Schuurman, Anirudh Tomer, K Martijn Akkerhuis, et al.
Heart (British Cardiac Society)|August 29, 2014
Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEFNick van Boven, Stephan Windecker, Victor A Umans, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 15, 2017
Development and validation of a risk model for long-term mortality after percutaneous coronary intervention: The IDEA-BIO StudyNick van Boven, Ron T van Domburg, Isabella Kardys, et al.
The American Journal of Cardiology|January 20, 2022
Relation of Iron Status to Prognosis After Acute Coronary SyndromeMuhammed T Gürgöze, Isabella Kardys, K Martijn Akkerhuis, et al.
Diabetes & Vascular Disease Research|December 1, 2021
IGF-1 is not related to long-term outcome in hyperglycemic acute coronary syndrome patientsCindya P Iswandi, Victor J van den Berg, Suat Simsek, et al.
Biology of Sex Differences|May 17, 2023
Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failureMarie de Bakker, Teun B Petersen, K Martijn Akkerhuis, et al.
International Journal of Cardiology|March 10, 2017
Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT studyNick van Boven, K Martijn Akkerhuis, Sharda S Anroedh, et al.
Obesity (Silver Spring, Md.)|July 23, 2024
Proteomic biomarkers related to obesity in heart failure with reduced ejection fraction and their associations with outcomeTeun B Petersen, Navin Suthahar, Folkert W Asselbergs, et al.
Ebiomedicine|June 16, 2023
HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanismsTeun B Petersen, Marie de Bakker, Folkert W Asselbergs, et al.
European Heart Journal. Digital Health|December 4, 2023
Machine learning-based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failureMarie de Bakker, Teun B Petersen, Anja J Rueten-Budde, et al.
Pageof 3